{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T15:13:39Z","timestamp":1648653219816},"reference-count":6,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2004,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Immunization with recombinant lipoprotein outer surface protein A vaccine is known to interfere with some serologic tests for Lyme disease. We tested sera from 152 vaccine recipients by using in-house and commercial Western blot assays and found that vaccination caused interference in up to 25% of recipients and can persist for over 6 years.<\/jats:p>","DOI":"10.1128\/cdli.11.4.808-810.2004","type":"journal-article","created":{"date-parts":[[2004,7,8]],"date-time":"2004-07-08T18:30:51Z","timestamp":1089311451000},"page":"808-810","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":1,"title":["Long-Term Effects of Immunization with Recombinant Lipoprotein Outer Surface Protein A on Serologic Test for Lyme Disease"],"prefix":"10.1128","volume":"11","author":[{"given":"Paul T.","family":"Fawcett","sequence":"first","affiliation":[{"name":"Immunology Laboratory, Department of Research"},{"name":"Division of Rheumatology, Department of Pediatrics, A. I. duPont Hospital for Children, Wilmington, Delaware"},{"name":"Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos D.","family":"Rose","sequence":"additional","affiliation":[{"name":"Immunology Laboratory, Department of Research"},{"name":"Division of Rheumatology, Department of Pediatrics, A. I. duPont Hospital for Children, Wilmington, Delaware"},{"name":"Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Maduskuie","sequence":"additional","affiliation":[{"name":"Immunology Laboratory, Department of Research"},{"name":"Division of Rheumatology, Department of Pediatrics, A. I. duPont Hospital for Children, Wilmington, Delaware"},{"name":"Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.37.11.3718-3721.1999"},{"key":"e_1_3_1_3_2","first-page":"590","volume":"44","year":"1995","unstructured":"Centers for Disease Control and Prevention. 1995. Recommendation for test performance and interpretation from Second National Conference on Serologic Diagnosis of Lyme Disease. Morb. Mortal. Wkly. Rep.44:590-591.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_1_4_2","first-page":"582","volume":"19","year":"1992","unstructured":"Fawcett, P. T., K. M. Gibney, C. D. Rose, S. B. Dubbs, and R. A. Doughty. 1992. Frequency and specificity of antibodies that cross-react with Borrelia Burgdorferi antigens. J. Rheumatol.19:582-587.","journal-title":"J. Rheumatol."},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.8.1.79-84.2001"},{"key":"e_1_3_1_6_2","first-page":"684","volume":"22","year":"1995","unstructured":"Fawcett, P. T., C. D. Rose, and K. M. Gibney. 1995. Comparative evaluation of adsorption with E. coli on ELISA tests from Lyme borreliosis. J. Rheumatol.22:684-688.","journal-title":"J. Rheumatol."},{"key":"e_1_3_1_7_2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1086\/313920","volume":"31","year":"2000","unstructured":"Molloy, P. J. V. P. Berardi, D. H. Persing, and L. H. Sigal. 2000. Detection of multiple reactive protein species by immunoblotting after outer recombinant surface protein A Lyme disease vaccination. Clin. Infect. Dis.31:42-47.","journal-title":"Clin. Infect. Dis."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CDLI.11.4.808-810.2004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CDLI.11.4.808-810.2004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:34:47Z","timestamp":1627590887000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CDLI.11.4.808-810.2004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":6,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["10.1128\/CDLI.11.4.808-810.2004"],"URL":"https:\/\/doi.org\/10.1128\/cdli.11.4.808-810.2004","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7]]},"assertion":[{"value":"2003-12-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-04-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}